Sartorius Aktiengesellschaft (SARTF)

Market Cap	16.46B -9.9%
Revenue (ttm)	4.13B +5.8%
Net Income	156.75M +72.2%
EPS	n/a
Shares Out	n/a
PE Ratio	104.98
Forward PE	35.51
Dividend	0.79 (0.35%)
Ex-Dividend Date	Mar 28, 2025

Volume	5
Average Volume	33
Open	226.33
Previous Close	225.00
Day's Range	226.33 - 226.33
52-Week Range	165.00 - 226.33
Beta	1.52
RSI	59.23
Earnings Date	Feb 3, 2026

About SARTF

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cy...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1870
• Employees: 13,878
• Stock Exchange: OTCMKTS
• Ticker Symbol: SARTF

Financial Performance

In 2024, SARTF's revenue was 3.38 billion, a decrease of -0.44% compared to the previous year's 3.40 billion. Earnings were 84.00 million, a decrease of -59.14%.

Financial numbers in EUR